Earlier, the US Food and Drug Administration (FDA) issued an emergency use authorization for a third COVID-19 vaccine, developed by Johnson & Johnson-owned Belgium-based pharmaceutical company Janssen. The drug was proved to be effective to approximately 77 percent. At the same time, the jab was said to cause a number of severe side effects.
